DE60235549D1 - Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika - Google Patents

Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika

Info

Publication number
DE60235549D1
DE60235549D1 DE60235549T DE60235549T DE60235549D1 DE 60235549 D1 DE60235549 D1 DE 60235549D1 DE 60235549 T DE60235549 T DE 60235549T DE 60235549 T DE60235549 T DE 60235549T DE 60235549 D1 DE60235549 D1 DE 60235549D1
Authority
DE
Germany
Prior art keywords
uea
mimetica
pharmaceutical formulation
ligands including
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60235549T
Other languages
German (de)
English (en)
Inventor
Richard Houghten
Clemencia Pinilla
Imelda Lambkin
Daniel O'mahony
Christa Hamashin
Amy Schink
Lisa Osthues-Spindler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sarlan Ltd
Original Assignee
Sarlan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarlan Ltd filed Critical Sarlan Ltd
Application granted granted Critical
Publication of DE60235549D1 publication Critical patent/DE60235549D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60235549T 2001-07-02 2002-07-02 Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika Expired - Fee Related DE60235549D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30282201P 2001-07-02 2001-07-02
US30286801P 2001-07-03 2001-07-03
PCT/US2002/020948 WO2003004062A1 (en) 2001-07-02 2002-07-02 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1

Publications (1)

Publication Number Publication Date
DE60235549D1 true DE60235549D1 (de) 2010-04-15

Family

ID=26973111

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235549T Expired - Fee Related DE60235549D1 (de) 2001-07-02 2002-07-02 Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika

Country Status (7)

Country Link
US (2) US7166296B2 (cg-RX-API-DMAC7.html)
EP (1) EP1404372B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004536109A (cg-RX-API-DMAC7.html)
AT (1) ATE459376T1 (cg-RX-API-DMAC7.html)
CA (1) CA2452257A1 (cg-RX-API-DMAC7.html)
DE (1) DE60235549D1 (cg-RX-API-DMAC7.html)
WO (1) WO2003004062A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP5114713B2 (ja) * 2005-11-01 2013-01-09 国立大学法人 熊本大学 腸管免疫賦活剤
KR101138312B1 (ko) 2009-04-13 2012-04-27 주식회사 바이오에프디엔씨 펩타이드 유도체 및 그를 포함하는 화장료 조성물
US20130004579A1 (en) 2011-05-13 2013-01-03 Lavelle Edward C Use of Plant Lectins to Target Leukocytes

Also Published As

Publication number Publication date
JP2004536109A (ja) 2004-12-02
WO2003004062A9 (en) 2003-04-10
US20040062796A1 (en) 2004-04-01
US20060276628A1 (en) 2006-12-07
EP1404372A1 (en) 2004-04-07
US7166296B2 (en) 2007-01-23
WO2003004062A1 (en) 2003-01-16
ATE459376T1 (de) 2010-03-15
EP1404372B1 (en) 2010-03-03
CA2452257A1 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BR0308090A (pt) conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
MXPA05002814A (es) Formulacion para agentes lipofilicos.
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
BRPI0608297A2 (pt) composições de lipossomos
PL360262A1 (pl) Kompozycje polimerycznych micelli
ATE355065T1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
MY129263A (en) Vaccine composition
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
EP1379508A4 (en) N- (ARYL) -2-ARYLETHESULFONAMIDES AND THEIR THERAPEUTIC APPLICATIONS
WO2006089114A3 (en) Methods and compositions for treating an anthrax toxin mediated condition
EP1491210A4 (en) THERAPEUTIC MEDICAMENT USING ANTIBODY PRESENTING HOLES PROTEIN NANOTEHICLES AND HIGH PROTEIN NANOTEHICLES
PL368686A1 (en) Novel aminobenzoephenones
ATE459376T1 (de) Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika
SE0001916D0 (sv) Novel formulation
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
DE60214476D1 (de) Pharmazeutische Zubereitungen, Wirkstoffe enthaltend, die sich für unerlaubte Verabreichung anbieten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee